Ellis van Liempt

2.0k total citations · 1 hit paper
20 papers, 1.7k citations indexed

About

Ellis van Liempt is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, Ellis van Liempt has authored 20 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 8 papers in Epidemiology and 6 papers in Molecular Biology. Recurrent topics in Ellis van Liempt's work include Immunotherapy and Immune Responses (8 papers), Cytomegalovirus and herpesvirus research (8 papers) and Virus-based gene therapy research (5 papers). Ellis van Liempt is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Cytomegalovirus and herpesvirus research (8 papers) and Virus-based gene therapy research (5 papers). Ellis van Liempt collaborates with scholars based in Netherlands, United States and Germany. Ellis van Liempt's co-authors include Yvette van Kooyk, Sandra J. van Vliet, Teunis B. H. Geijtenbeek, Anneke Engering, Christine M.C. Bank, Vincent Piguet, Mietske Wijers, Antonio Lanzavecchia, Jack Fransen and Nicolas Demaurex and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Ellis van Liempt

20 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Dendritic Cell-Specific Adhesion Receptor DC-SIGN Internalizes Antigen for Presentation to T Cells

2002 514 citations Anneke Engering, Teunis B. H. Geijtenbeek et al. The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ellis van Liempt Netherlands	14	1.0k	555	312	292	189	20	1.7k
Ajesh Maewal United States	12	658 0.7×	557 1.0×	160 0.5×	286 1.0×	102 0.5×	13	1.1k
Jens Zerrahn Germany	20	1.2k 1.2×	356 0.6×	358 1.1×	634 2.2×	189 1.0×	27	2.0k
Edith Dériaud France	29	1.6k 1.6×	945 1.7×	152 0.5×	541 1.9×	591 3.1×	49	2.7k
J. Mauricio Calvo‐Calle United States	24	594 0.6×	737 1.3×	96 0.3×	345 1.2×	226 1.2×	39	1.5k
Hélène Gras-Masse France	24	519 0.5×	635 1.1×	334 1.1×	319 1.1×	117 0.6×	51	1.5k
Isabelle Dimier‐Poisson France	27	537 0.5×	606 1.1×	966 3.1×	716 2.5×	217 1.1×	77	1.9k
Franck Halary France	22	1.2k 1.2×	375 0.7×	44 0.1×	382 1.3×	206 1.1×	44	1.8k
Marion Becker United Kingdom	19	485 0.5×	627 1.1×	285 0.9×	378 1.3×	229 1.2×	32	1.6k
Marı́a Colmenares Spain	24	505 0.5×	268 0.5×	202 0.6×	615 2.1×	146 0.8×	34	1.6k
Michael R. Knittler Germany	19	441 0.4×	613 1.1×	125 0.4×	331 1.1×	153 0.8×	43	1.4k

Countries citing papers authored by Ellis van Liempt

Since Specialization

Citations

This map shows the geographic impact of Ellis van Liempt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellis van Liempt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellis van Liempt more than expected).

Fields of papers citing papers by Ellis van Liempt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellis van Liempt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellis van Liempt. The network helps show where Ellis van Liempt may publish in the future.

Co-authorship network of co-authors of Ellis van Liempt

This figure shows the co-authorship network connecting the top 25 collaborators of Ellis van Liempt. A scholar is included among the top collaborators of Ellis van Liempt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellis van Liempt. Ellis van Liempt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Balen, Peter van, Lothar Germeroth, Lois Hageman, et al.. (2019). Generation and infusion of multi-antigen-specific T cells to prevent complications early after T-cell depleted allogeneic stem cell transplantation—a phase I/II study. Leukemia. 34(3). 831–844. 19 indexed citations

Hageman, Lois, Ellis van Liempt, Michel G.D. Kester, et al.. (2018). The simultaneous isolation of multiple high and low frequent T-cell populations from donor peripheral blood mononuclear cells using the major histocompatibility complex I-Streptamer isolation technology. Cytotherapy. 20(4). 543–555. 9 indexed citations

Balen, Peter van, Lois Hageman, Ellis van Liempt, et al.. (2016). Prevention of Viral Infections after T Cell Depleted Allogeneic Stem Cell Transplantation By Infusion of Multi-Antigen Specific T Cell Products. Blood. 128(22). 1228–1228. 2 indexed citations

Loenen, Marleen M. van, Renate de Boer, Ellis van Liempt, et al.. (2013). A Good Manufacturing Practice procedure to engineer donor virus-specific T cells into potent anti-leukemic effector cells. Haematologica. 99(4). 759–768. 37 indexed citations

Zandvliet, Maarten L., Michel G.D. Kester, Ellis van Liempt, et al.. (2012). Efficiency and Mechanism of Antigen-specific CD8+ T-cell Activation Using Synthetic Long Peptides. Journal of Immunotherapy. 35(2). 142–153. 4 indexed citations

Meij, Pauline, Inge Jedema, Maarten L. Zandvliet, et al.. (2012). Effective Treatment of Refractory CMV Reactivation After Allogeneic Stem Cell Transplantation With In Vitro-generated CMV pp65-specific CD8+ T-cell Lines. Journal of Immunotherapy. 35(8). 621–628. 46 indexed citations

Zandvliet, Maarten L., Ellis van Liempt, Inge Jedema, et al.. (2011). Simultaneous Isolation of CD8+ and CD4+ T Cells Specific for Multiple Viruses for Broad Antiviral Immune Reconstitution After Allogeneic Stem Cell Transplantation. Journal of Immunotherapy. 34(3). 307–319. 35 indexed citations

Zandvliet, Maarten L., J.H. Frederik Falkenburg, Ellis van Liempt, et al.. (2010). Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection. Haematologica. 95(11). 1943–1951. 54 indexed citations

Zandvliet, Maarten L., Ellis van Liempt, Inge Jedema, et al.. (2010). Co-ordinated isolation of CD8+ and CD4+ T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy. Cytotherapy. 12(7). 933–944. 20 indexed citations

10.

Zandvliet, Maarten L., Ellis van Liempt, Louise A. Veltrop‐Duits, et al.. (2010). Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection Running head: M. Zandvliet et al. HAdV-specific T cells after alloSCT. 2 indexed citations

11.

García‐Vallejo, Juan J., Ellis van Liempt, Paula A. da Costa Martins, et al.. (2008). DC-SIGN mediates adhesion and rolling of dendritic cells on primary human umbilical vein endothelial cells through LewisY antigen expressed on ICAM-2. Molecular Immunology. 45(8). 2359–2369. 50 indexed citations

12.

Liempt, Ellis van, Sandra J. van Vliet, Anneke Engering, et al.. (2007). Schistosoma mansoni soluble egg antigens are internalized by human dendritic cells through multiple C-type lectins and suppress TLR-induced dendritic cell activation. Molecular Immunology. 44(10). 2605–2615. 208 indexed citations

13.

Vliet, Sandra J. van, Ellis van Liempt, Teunis B. H. Geijtenbeek, & Yvette van Kooyk. (2006). Differential regulation of C-type lectin expression on tolerogenic dendritic cell subsets. Immunobiology. 211(6-8). 577–585. 69 indexed citations

14.

Liempt, Ellis van, Christine M.C. Bank, Padmaja Mehta, et al.. (2006). Specificity of DC‐SIGN for mannose‐ and fucose‐containing glycans. FEBS Letters. 580(26). 6123–6131. 220 indexed citations

15.

Die, Irma van, Ellis van Liempt, Christine M.C. Bank, & Wietske E.C.M. Schiphorst. (2005). Interaction of Schistosome Glycans with the Host Immune System. Advances in experimental medicine and biology. 564. 9–19. 3 indexed citations

16.

Vliet, Sandra J. van, Ellis van Liempt, Eiríkur Saeland, et al.. (2005). Carbohydrate profiling reveals a distinctive role for the C-type lectin MGL in the recognition of helminth parasites and tumor antigens by dendritic cells. International Immunology. 17(5). 661–669. 192 indexed citations

17.

Meyer, Sandra De, Ellis van Liempt, Anne Imberty, et al.. (2005). DC-SIGN Mediates Binding of Dendritic Cells to Authentic Pseudo-LewisY Glycolipids of Schistosoma mansoni Cercariae, the First Parasite-specific Ligand of DC-SIGN. Journal of Biological Chemistry. 280(45). 37349–37359. 82 indexed citations

18.

Liempt, Ellis van, Anne Imberty, Christine M.C. Bank, et al.. (2004). Molecular Basis of the Differences in Binding Properties of the Highly Related C-type Lectins DC-SIGN and L-SIGN to Lewis X Trisaccharide and Schistosoma mansoni Egg Antigens. Journal of Biological Chemistry. 279(32). 33161–33167. 85 indexed citations

19.

Stortelers, Catelijne, et al.. (2002). Role of the N-Terminus of Epidermal Growth Factor in ErbB-2/ErbB-3 Binding Studied by Phage Display. Biochemistry. 41(27). 8732–8741. 11 indexed citations

20.

Engering, Anneke, Teunis B. H. Geijtenbeek, Sandra J. van Vliet, et al.. (2002). The Dendritic Cell-Specific Adhesion Receptor DC-SIGN Internalizes Antigen for Presentation to T Cells. The Journal of Immunology. 168(5). 2118–2126. 514 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact